Practice areas

Capital markets; Private equity venture; M&A; Corporate & commercial

Introduction

Fu Yangyuan is senior partner and the co-principal of financing business of Jia Yuan Law Offices, and is now a member of the securities business research committee of the Shanghai Bar Association. She mainly specialises in capital markets, private equity ventures, M&A, and corporate and commercial.

Fu has more than 15 years of practical experience gained through legal service in capital markets. She has been in charge of the domestic and foreign listing projects of dozens of enterprises and many private equity venture projects, and she is highly recognised by customers, peers and the market with her excellent legal service quality and problem-solving ability. Fu is one of the few commercial lawyers running through both the trading side (investment, financing and M&A) and the exiting side (domestic and foreign listing and M&A of listed companies), and is experienced in the complex information disclosure rules involved in both domestic and foreign listings, overall listing and equity carve-outs and dual listings, since her focus on investment and financing, M&A and domestic and foreign capital markets over the past 15 years.

Fu also has an in-depth understanding and practical experience of projects related to healthcare, semiconductor integrated circuits, consumption, information technology and the automobile industry. She has led many well-known benchmarking projects including Tigermed’s A- and H-share listings; SAIC’s non-public offering; Amlogic’s A-share listing on the STAR market; Microport’s equity carve-out; and MedBot’s H-share listing. With her comprehensive knowledge structure, profound professional skills and excellent business mind in the field of capital markets, Fu can analyse projects accurately and efficiently, and formulate the best solution strategy for complicated and changeable practical problems so as to maximise the interests of customers and ensure legal services of high quality.

Back to China A-List 2021